Search research articles
Contact Us
Filters
Showing results (151-160 of 197) with videos related to
Page
of 20
Sort By:
Nuclear Medicine and Biology
|
October 11, 2011
Comparisons of [18F]-1-deoxy-1-fluoro-scyllo-inositol with [18F]-FDG for PET imaging of inflammation, breast and brain cancer xenografts in athymic mice
Kristin McLarty, Matthew D Moran, Deborah A Scollard, et al.
EJNMMI Radiopharmacy and Chemistry
|
May 21, 2020
Synthesis, in vitro and in vivo evaluation of <sup>11</sup>C-O-methylated arylpiperazines as potential serotonin 1A (5-HT<sub>1A</sub>) receptor antagonist radiotracers
Vidya Narayanaswami, Junchao Tong, Ferdinando Fiorino, et al.
International Journal of Medicinal Chemistry
|
December 5, 2017
Fluorinated Adenosine A<sub>2A</sub> Receptor Antagonists Inspired by Preladenant as Potential Cancer Immunotherapeutics
Gengyang Yuan, Tanner C Jankins, Christopher G Patrick, et al.
JAMA Neurology
|
February 28, 2017
Association of In Vivo [18F]AV-1451 Tau PET Imaging Results With Cortical Atrophy and Symptoms in Typical and Atypical Alzheimer Disease
Chenjie Xia, Sara J Makaretz, Christina Caso, et al.
JAMA Psychiatry
|
March 7, 2019
Monoamine Oxidase B Total Distribution Volume in the Prefrontal Cortex of Major Depressive Disorder: An [11C]SL25.1188 Positron Emission Tomography Study
Sho Moriguchi, Alan A Wilson, Laura Miler, et al.
Journal of Labelled Compounds & Radiopharmaceuticals
|
February 11, 2017
cGMP production of the radiopharmaceutical [<sup>18</sup> F]MK-6240 for PET imaging of human neurofibrillary tangles
Thomas Lee Collier, Daniel L Yokell, Eli Livni, et al.
Nature Communications
|
June 14, 2024
Ligand-based design of [<sup>18</sup>F]OXD-2314 for PET imaging in non-Alzheimer's disease tauopathies
Anton Lindberg, Emily Murrell, Junchao Tong, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
September 24, 2016
Pharmacokinetic Evaluation of the Tau PET Radiotracer <sup>18</sup>F-T807 (<sup>18</sup>F-AV-1451) in Human Subjects
Dustin W Wooten, Nicolas J Guehl, Eline E Verwer, et al.
Acta Pharmaceutica Sinica. B
|
March 1, 2021
Recent developments on PET radiotracers for TSPO and their applications in neuroimaging
Lingling Zhang, Kuan Hu, Tuo Shao, et al.
ACS Medicinal Chemistry Letters
|
September 24, 2015
Novel Fluorinated 8-Hydroxyquinoline Based Metal Ionophores for Exploring the Metal Hypothesis of Alzheimer's Disease
Steven H Liang, Adam G Southon, Benjamin H Fraser, et al.
Page
of 20
Search research articles
Search
Showing results (151-160 of 197) with videos related to
Sort By:
Page
of 20
Nuclear Medicine and Biology
|
October 11, 2011
Comparisons of [18F]-1-deoxy-1-fluoro-scyllo-inositol with [18F]-FDG for PET imaging of inflammation, breast and brain cancer xenografts in athymic mice
Kristin McLarty, Matthew D Moran, Deborah A Scollard, et al.
EJNMMI Radiopharmacy and Chemistry
|
May 21, 2020
Synthesis, in vitro and in vivo evaluation of <sup>11</sup>C-O-methylated arylpiperazines as potential serotonin 1A (5-HT<sub>1A</sub>) receptor antagonist radiotracers
Vidya Narayanaswami, Junchao Tong, Ferdinando Fiorino, et al.
International Journal of Medicinal Chemistry
|
December 5, 2017
Fluorinated Adenosine A<sub>2A</sub> Receptor Antagonists Inspired by Preladenant as Potential Cancer Immunotherapeutics
Gengyang Yuan, Tanner C Jankins, Christopher G Patrick, et al.
JAMA Neurology
|
February 28, 2017
Association of In Vivo [18F]AV-1451 Tau PET Imaging Results With Cortical Atrophy and Symptoms in Typical and Atypical Alzheimer Disease
Chenjie Xia, Sara J Makaretz, Christina Caso, et al.
JAMA Psychiatry
|
March 7, 2019
Monoamine Oxidase B Total Distribution Volume in the Prefrontal Cortex of Major Depressive Disorder: An [11C]SL25.1188 Positron Emission Tomography Study
Sho Moriguchi, Alan A Wilson, Laura Miler, et al.
Journal of Labelled Compounds & Radiopharmaceuticals
|
February 11, 2017
cGMP production of the radiopharmaceutical [<sup>18</sup> F]MK-6240 for PET imaging of human neurofibrillary tangles
Thomas Lee Collier, Daniel L Yokell, Eli Livni, et al.
Nature Communications
|
June 14, 2024
Ligand-based design of [<sup>18</sup>F]OXD-2314 for PET imaging in non-Alzheimer's disease tauopathies
Anton Lindberg, Emily Murrell, Junchao Tong, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
September 24, 2016
Pharmacokinetic Evaluation of the Tau PET Radiotracer <sup>18</sup>F-T807 (<sup>18</sup>F-AV-1451) in Human Subjects
Dustin W Wooten, Nicolas J Guehl, Eline E Verwer, et al.
Acta Pharmaceutica Sinica. B
|
March 1, 2021
Recent developments on PET radiotracers for TSPO and their applications in neuroimaging
Lingling Zhang, Kuan Hu, Tuo Shao, et al.
ACS Medicinal Chemistry Letters
|
September 24, 2015
Novel Fluorinated 8-Hydroxyquinoline Based Metal Ionophores for Exploring the Metal Hypothesis of Alzheimer's Disease
Steven H Liang, Adam G Southon, Benjamin H Fraser, et al.
Page
of 20